Otrivine with fine nasal mist^*

Go To

About Otrivine with fine nasal mist^*
How to use Otrivine with fine nasal mist^*
Product Information

Otrivine with fine nasal mist^*

Otrivine products with the fine nasal mist nozzle offer the same trusted congestion relief as the previous device but with a better patient experience.

Last year, almost 70% of people suffered from nasal symptoms.¹ Yet, in many countries, less than 1 in 2 people used nasal sprays to treat their nasal congestion.¹

*nozzle provides fine mist

Otrivine with fine nasal mist benefits and product features

Otrivine with fine nasal mist* features patented^† technology for comfortable congestion treatment.²

Product features and benefits include:

An ergonomic design meaning it’s easier** to hold.²
A gentle mist that reaches wider** to inflamed areas in the nose.³
Designed not to drip in the back of the throat.³
A 2x shorter nozzle length, ensuring greater comfort in the nose vs the previous device.²

*nozzle provides fine mist**vs. previous device†Patent number EP2654967B1

Otrivine Fine Nasal Mist^*

Otrivine with fine nasal mist* product benefits

Patented^† technology

A patented^† technology that delivers a fine mist* which feels comfortable and gentle in the nose.²

†EP2654967B1*nozzle provides fine mist

Benefits of fine nasal mist^*

The fine mist* spray reaches wider to inflamed areas^† in the nasal cavity.³ Otrivine spray provides effective congestion relief.

*nozzle provides fine mist†vs previous device

Designed not to drip at the back of the throat

Otrivine with fine nasal mist has a lateral actuation system that produces a fine mist* and is designed not to drip down the throat.²

The aftertaste and irritation from drippage down the throat after using nasal sprays are a couple of reasons that patients would not wish to use a nasal spray.¹

*nozzle provides fine mist
An easy-to-use design

1-thumb action

More comfortable and easier to use,^*4 its 1-thumb action allows for easy and controlled administration with the push of a button.²

*vs the previous device

2x shorter nozzle length

A shorter nozzle can feel less invasive in the nose,* increasing comfort and supporting ease of administration.²

*vs previous device.

Recommend Otrivine with fine nasal mist

Otrivine Fine Nasal Mist^*

Otrivine with fine nasal mist* has a patented^†technology for comfortable congestion treatment.^2-4

*nozzle provides fine mist†EP2654967B1

Otrivine Fine Nasal Mist product details

Product information – Otrivine Extra Dual Relief

Full information can be found in the Summary of Product Characteristics.

Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution (xylometazoline hydrochloride, ipratropium bromide).

Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds.

Dosage: Adults: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Maximum 3 applications daily into each nostril. Do not exceed the stated dose. Do not use for longer than 7 days. It is recommended to stop treatment when the symptoms have diminished, even before the maximum duration of treatment of 7 days. Geriatrics: Limited experience of use in patients above 70 years of age.

Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride, ipratropium bromide, any of the excipients, atropine or atropine-like substances. Patients with glaucoma, rhinitis sicca, atrophic rhinitis or following trans-sphenoidal hypophysectomy or surgery penetrating the dura mater.

Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, long QT syndrome, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, on monoamine oxidase inhibitors treatment or tri/tetra cyclic antidepressants (or have been on either within the last two weeks), on beta 2-agonist treatment, cystic fibrosis. Use with caution in patients predisposed to angle closure glaucoma, epistaxis or paralytic ileus. Immediate hypersensitivity including urticaria, angioedema, rash, bronchospasm, pharyngeal oedema and anaphylaxis may occur. Caution in people sensitive to adrenergic substances. Avoid contact with eyes.

Side effects: See SPC for full details. Very common: epistaxis. Common: dysgeusia, rhinalgia, nasal congestion, headache, nasal dryness, nasal discomfort, nausea, application site burn, dizziness, throat irritation, dry throat, dry mouth.

Price: £6.66 (ex. VAT)

Legal Status: P.

Licence Number: PL 15545/0002.

Licence Holder: Haleon Ireland Dungarvan Limited, Knockbrack, Dungarvan, County Waterford, Ireland.

Date of revision: September 2025
Product Information – Otrivine Sinusitis Relief and Otrivine Allergy Relief

Full information can be found in the Summary of Product Characteristics.

Otrivine Sinusitis Relief, 0.1% w/v Nasal Spray, Solution / Otrivine Blocked Nose Relief, 0.1% w/v Nasal Spray, Solution/ Otrivine Allergy Relief, 0.1% Nasal Spray. (Xylometazoline Hydrochloride).

Indications:For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

Dosage: Adults, children over 12 years and the elderly: One application in each nostril up to 3 times daily. Do not exceed 3 applications daily into each nostril. Not suitable for children under 12 years.

Contraindications: Hypersensitivity to xylometazoline. Trans-sphenoidal hypophysectomy or surgery exposing the dura mater, narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years.

Warnings and precautions: Do not take for more than seven consecutive days. Use with Caution in patients showing a strong reaction to sympathomimetic agents, with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus and those taking tri and tetra-cyclic antidepressant treatment. Patients with long QT syndrome may be at increased risk of serious ventricular arrhythmias. Contains benzalkonium chloride, may cause irritation of the nasal mucosa.

Side effects: See SmPC for full details. Common: Application site burning, nausea, headache, nasal dryness and nasal discomfort.

MRSP (excl VAT): Blocked Nose Relief Freepod spray: £3.96; Allergy Relief and Sinusitis Relief Khone spray: £4.40

Legal Status: GSL.

Licence Number: PL 44673/0184.

Licence Holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.

Date of revision: Nov 2025.
Product Information – Otrivine Congestion Relief 

Full information can be found in the Summary of Product Characteristics.

Otrivine Congestion Relief 0.1% Nasal Spray. (Xylometazoline Hydrochloride).

Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

Dosage: Adults and adolescents over 12 years of age: 1 spray into each nostril, up to 3 times daily as needed. Do not exceed 3 applications daily into each nostril. Do not use in children under 12.

Contraindications: Hypersensitivity to the active substance or to any of the excipients. Trans-sphenoidal hypophysectomy or surgery exposing the dura mater, narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Do not use in children under 12 years.

Warnings and precautions: Do not take for more than seven consecutive days. Use with caution in patients showing a strong reaction to adrenergic substances, with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus and those taking tri and tetra-cyclic antidepressant treatment. Patients with long QT syndrome may be at increased risk of serious ventricular arrhythmias. This medicine contains polyoxyl hydrogenated castor oil which may cause skin reactions.

Side effects:  See SPC for full details. Common: Application site burning, nausea, headache, nasal dryness and nasal discomfort.

MRSP (excl VAT): £5

Legal Status: GSL.

Licence Number: PL 44673/0151.

Licence Holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.

Date of revision: Oct 2025.